Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease

ConclusionOur findings suggest albumin binding function is a novel biomarker for early liver damage and disease progression in NAFLD.
Source: Endocrine - Category: Endocrinology Source Type: research